Reply to comments on 'COVID-19 in patients with neuroendocrine neoplasms: Preliminary results of a worldwide survey (The INTENSIVE study)'

Eur J Cancer. 2021 Nov:157:531-532. doi: 10.1016/j.ejca.2021.08.021. Epub 2021 Aug 23.

Authors

Nicola Fazio¹, Francesca Spada², Lorenzo Gervaso²

Affiliations

¹ Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, IEO, European Institute of Oncology, IRCCS, Milan, Italy. Electronic address: [email protected].
² Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, IEO, European Institute of Oncology, IRCCS, Milan, Italy.

No abstract available

Publication types

Letter
Comment

MeSH terms

COVID-19*
Humans
Neuroendocrine Tumors* / epidemiology
SARS-CoV-2
Surveys and Questionnaires